UVFT — UV Flu Technologies Share Price
- $0.01m
- $0.26m
- $0.18m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.07 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -345.24% |
Financial Summary
Year End 30th Sep | Unit | 2011 | 2012 | 2013 | 2014 | 2015 | 2016E | 2017E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 0.16 | 0.16 | 0.21 | 0.11 | 0.18 | n/a | n/a | 10.26% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
UV Flu Technologies, Inc. is engaged in the research, development, manufacturing and sales of air purification systems and products. The Company provides air purification systems in the workplace and at home with technology utilizing high-energy ultraviolet radiation (UV) inside a killing chamber, which destroys airborne bacteria, viruses and allergens. The product also reduces odors and the concentrations of volatile organic compounds (VOCs). The Company's product lines include RX-3000, a hospital-grade high-efficiency particulate air (HEPA) air filter; CR-3000, a construction grade version of the RX-3000; RX-4000, a prototype, metal cabinet wall-mounted commercial version of the RX-3000; RX-4500, a commercial version of the RX-3000, which can cover hospital and casino spaces till approximately 10,000 square feet; RX-6500, a bio-terrorism version of RX-4500, and RX Air Plus, a system that combines the RX-3000 and over two Viratech UV-400s to form an air filtration system.
Directors
- Last Annual
- September 30th, 2015
- Last Interim
- March 31st, 2016
- Incorporated
- April 4th, 2006
- Public Since
- September 5th, 2008
- No. of Employees
- 3
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 134,164,028
- Address
- 250 PARKWAY DRIVE, SUITE 150, LINCOLNSHIRE, 60069
- Web
- http://www.uvflutech.com/
- Phone
- +1 5083625455
- Auditors
- KMJ Corbin & Company LLP
Similar to UVFT
3DX Industries
Pink Sheets on Nasdaq
420 Property Management
Pink Sheets on Nasdaq
Abb
Pink Sheets on Nasdaq
Abound Energy
Pink Sheets on Nasdaq
Allego NV
Pink Sheets on Nasdaq
FAQ
As of Today at 22:54 UTC, shares in UV Flu Technologies are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in UV Flu Technologies last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the UV Flu Technologies share price has underperformed the S&P500 Index by -13.47% over the past year.
There is no consensus recommendation for this security.
Find out moreUV Flu Technologies does not currently pay a dividend.
UV Flu Technologies does not currently pay a dividend.
UV Flu Technologies does not currently pay a dividend.
To buy shares in UV Flu Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in UV Flu Technologies had a market capitalisation of $0.01m.
Here are the trading details for UV Flu Technologies:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: UVFT
Based on an overall assessment of its quality, value and momentum UV Flu Technologies is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like UV Flu Technologies. Over the past six months, its share price has underperformed the S&P500 Index by -1.75%.
As of the last closing price of $0.00, shares in UV Flu Technologies were trading -94.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The UV Flu Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
UV Flu Technologies' management team is headed by:
- Michael Ross - PRE
- Jerrold Leikin - IND
- Thomas Mahowald - IND
- Jeremy Noonan - IND